首页> 外文期刊>Journal of neuro-oncology. >MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP)
【24h】

MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP)

机译:使用小动物辐射研究平台(SARRP)对F98胶质母细胞瘤大鼠模型进行MRI引导的3D保形弧微辐照

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Current glioblastoma (GB) small animal models for cranial radiation therapy (RT) use simple single beam technologies, which differ from the advanced conformal image-guided radiation techniques used in clinical practice. This technological disparity presents a major disadvantage for the development of new therapeutic approaches. Hence, we established a F98 GB rat model using magnetic resonance imaging (MRI)-guided three-dimensional (3D)-conformal arc RT with the Small Animal Radiation Research Platform (SARRP). Ten Fischer rats were inoculated with F98 tumor cells. When the tumor reached a volume of approximately 27 mm3 on T2-weighted MR images, the animals were randomized into a treatment group (n = 5) receiving RT and concomitant temozolomide, and a sham group (n = 5) receiving control injections. For the treated animals, contrast-enhanced T1-weighted MR images were acquired followed by a cone-beam computed tomography (CBCT) on the SARRP system. Both scans were co-registered; MRI was used to define the target whereas CBCT was used for calculating a dose plan (20 Gy, three non-coplanar arc beams, 3 × 3 mm collimator). Tumor volumes were evaluated on follow-up contrast-enhanced T1-weighted MR images. Verification of treatment accuracy with γH2AX immunohistochemical staining was performed. Tumors in the control animals showed rapid proliferation during follow-up, encompassing almost the entire right cerebral hemisphere at day 12–15. Treated animals showed no significant tumor growth from 2 to 9 days post RT. γH2AX results confirmed the accuracy of dose delivery. This model, which is quite similar to the approach in the clinic, is valid for combined RT and chemotherapy of GB in rats.
机译:当前用于颅脑放射治疗(RT)的胶质母细胞瘤(GB)小动物模型使用简单的单束技术,这与临床实践中使用的先进的保形影像引导放射技术不同。这种技术差异为开发新的治疗方法带来了主要缺点。因此,我们使用磁共振成像(MRI)引导的三维(3D)保形弧RT和小动物辐射研究平台(SARRP)建立了F98 GB大鼠模型。用F98肿瘤细胞接种十只Fischer大鼠。当在T2加权MR图像上肿瘤达到约27 mm3的体积时,将动物随机分为接受RT和伴随替莫唑胺治疗的治疗组(n = 5)和接受对照注射的假手术组(n = 5)。对于治疗的动物,先获取对比增强的T1加权MR图像,然后在SARRP系统上进行锥形束计算机断层扫描(CBCT)。两次扫描均已注册。 MRI用于确定目标,而CBCT用于计算剂量计划(20 Gy,三个非共面弧形光束,3×3 mm准直仪)。在随访对比增强的T1加权MR图像上评估肿瘤体积。用γH2AX免疫组化染色验证治疗的准确性。对照动物的肿瘤在随访过程中显示出快速增殖,在第12-15天几乎涵盖了整个右脑半球。在RT后2至9天,经治疗的动物没有显示出明显的肿瘤生长。 γH2AX结果证实了剂量输送的准确性。该模型与临床方法非常相似,适用于大鼠RT和GB联合化疗。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号